Millenia Hope Inc., a biopharma corporation, announced that its Canadian subsidiary, Millenia Hope Biopharma (MH-B), has purchased the intellectual property, scientific expertise and the research facilities of the former Avance Pharma. Avance Pharma is a leading bio-research firm in phytomic technology, the commercialization of plant cell cultures. Avance has spent over US$30 million to create its unique technology, including a collection of highly purified phyto-chemical fractions to be utilized in the pharmaceutical, cosmetic and nutraceutical industry.
The company says that because of its cutting-edge technology, it has been the recipient of several R&D grants. MH-B, retaining Avance's world-class research personnel and all of its operating assets and facilities, reportedly is working to complete the initial commercialization of several projects with leading multi-national corporations. These projects will produce immediate revenues, milestone payments and future royalties, based on specific criteria.
!['Snoopy and Woodstock are cherished [characters] across generations and pairing them with our most-loved body care essentials creates a collection that feels classic with a modern twist. This launch is about celebrating our community with something unforgettable while starting an exciting new era for the brand,' said Luis Garcia, Chief Marketing Officer.](https://img.cosmeticsandtoiletries.com/mindful/allured/workspaces/default/uploads/2025/10/tree-hut-peanuts-fullcollection-fall26-1x1-1253.lGcuurUszp.jpg?auto=format%2Ccompress&fit=crop&h=191&q=70&w=340)
